Ben Coleman MP: speeches
4 Jul 2026–16 Oct 2026 · year in progress
How these years work
Our reporting years run from 4 July to 3 July, starting with the 2024 general election. They are not official parliamentary sessions. Office costs keep IPSA’s April–March financial years. Records may cover only part of a year; a missing record does not mean no work was done.
Read what this MP said, asked and contributed in Parliament.
1 published records · newest first.
Speeches
- 3 Sept 2026 · Vaccination Rates: England · Hansard source
More
It is a pleasure to serve under your chairship, Mrs Barker. I thank my hon. Friend the Member for Uxbridge and South Ruislip (Danny Beales) and colleagues on the Health and Social Care Committee for securing this important debate. I am particularly concerned about the fall in childhood vaccination rates and what that means for diseases such as measles, which we had all but eliminated. Before I entered Parliament, I served as a councillor on the North West London integrated care board. Because our figures were so poor, I pushed for North West London NHS to deliver MMR vaccinations through community pharmacies. All families go to pharmacies, so it seemed an obvious thing to do, but I was told that it was simply too complicated. I pushed a bit, and I got two pharmacies into a sort of project. It was a start, but it was nowhere near enough. When I became a member of the Health and Social Care Committee, then, I was delighted to have the opportunity to pursue the matter. As has been mentioned, when NHS England and UK Health Security Agency officials came before the Committee in February, warning signs were already flashing red. The UK had lost its measles elimination status, London had the lowest childhood vaccination coverage in the country, and children were being hospitalised by a disease that is entirely preventable. It was extraordinary: I was strongly struck by the feeling they gave off of a complete lack of urgency in how they saw the problem. I asked whether anyone had assessed the cost to the NHS of under-vaccination; the answer was no. I asked why a pharmacy MMR pilot across 43 sites in the north-west had not continued; I was told that it had worked as a campaign, but making it routine was “a different question”. I asked whether that question was even being assessed, and it clearly was not. Sadly, since the Committee’s inquiry the situation has got worse, not better. As my hon. Friend the Member for Uxbridge and South Ruislip touched on, UKHSA data shows that, as of 17 August, England had recorded 970 laboratory-confirmed measles cases this year alone. Of those, 650 patients were children aged 14 or under, and more than half of all cases were in London. I am not saying that pharmacies are silver bullets—the Committee also heard arguments about strengthening school-age immunisation services—but it should not be either/or. It should be schools, GPs and pharmacies. We should use every available route to help our children and their families. Officials told the Committee that they do not want to use pharmacies for childhood vaccination because they still do not know whether the evidence supports it. Surely, Minister, the obvious answer is to get the evidence. What are the Government doing to get the evidence? Will they get it by commissioning a proper evaluation of the use of pharmacies for routine MMR vaccination, with a clear deadline? In short, will the Minister ensure that the NHS stops prevaricating and acts before more children pay the price?
Explore activity by topic or department
Contributions by debate topic
4 Jul 2026–16 Oct 2026. Existing keyword taxonomy applied to official debate titles and contributions; a contribution may appear in more than one topic and unclassified records are retained.
View as listWhat this shows and doesn't show
Published records only — not a full account of an MP’s work. How we work →